Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 263

Similar articles for PubMed (Select 24175223)

1.

Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Chen LP, Zhao J, Du Y, Han YF, Su T, Zhang HW, Cao GW.

World J Virol. 2012 Dec 12;1(6):174-83. doi: 10.5501/wjv.v1.i6.174. Review.

2.
3.

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.

4.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
5.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
6.

Impact of HBV therapy on the incidence of hepatocellular carcinoma.

Triolo M, Della Corte C, Colombo M.

Liver Int. 2014 Feb;34 Suppl 1:139-45. doi: 10.1111/liv.12394. Review.

PMID:
24373091
7.

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

Yang SC, Lee CM, Hu TH, Wang JH, Lu SN, Hung CH, Changchien CS, Chen CH.

J Antimicrob Chemother. 2013 Sep;68(9):2154-63. doi: 10.1093/jac/dkt147. Epub 2013 Apr 25.

8.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
9.

Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

Vlachogiannakos J, Papatheodoridis G.

World J Gastroenterol. 2013 Dec 21;19(47):8822-30. doi: 10.3748/wjg.v19.i47.8822. Review.

10.

Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.

Hung CH, Lu SN, Wang JH, Hu TH, Chen CH, Huang CM, Lee CM.

Antivir Ther. 2011;16(7):959-68. doi: 10.3851/IMP1842.

PMID:
22024511
11.

Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.

Chong CC, Wong GL, Lai PB.

World J Gastroenterol. 2014 May 28;20(20):6006-12. doi: 10.3748/wjg.v20.i20.6006. Review.

12.

Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Keating GM.

Drugs. 2011 Dec 24;71(18):2511-29. doi: 10.2165/11208510-000000000-00000. Review.

PMID:
22141390
13.

Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.

Riediger C, Berberat PO, Sauer P, Gotthardt D, Weiss KH, Mehrabi A, Merle U, Stremmel W, Encke J.

Nephrol Dial Transplant. 2007 Sep;22 Suppl 8:viii37-viii46. Review.

14.

[Interferon in hepatitis B].

García Buey L, González Mateos F, Moreno Otero R.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 7:19-31. Review. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Dec;26(10):675.

PMID:
19100228
15.

Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation.

Pipili C, Cholongitas E.

World J Hepatol. 2014 May 27;6(5):315-25. doi: 10.4254/wjh.v6.i5.315. Review.

16.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
17.

Management of chronic hepatitis B.

Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.

18.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
19.

Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.

Wang JY.

J Dig Dis. 2012 Nov;13(11):555-7. doi: 10.1111/j.1751-2980.2012.00630.x.

PMID:
23107441
20.

[Monitoring patients with chronic hepatitis during and after therapy].

Colić-Cvrlje V, Mise S.

Acta Med Croatica. 2009 Dec;63(5):377-83. Croatian.

PMID:
20198895
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk